Susanna Naggie

Vice Dean for Clinical Research · Duke University Hospital

Credentials: · · · · · · ·

History

CTSA UM1 at Duke University
National Center for Advancing Translational Sciences · UM1
Contact PI · $19.7M · Duke University
2025–2032
Combating Related Epidemics in HCV Through Simplified Testing and Treatment (CREST)
National Institute of Allergy and Infectious Diseases · U01
Contact PI · $7M · Duke University
2025–2030
Center for AIDS Research
National Institute of Allergy and Infectious Diseases · P30
PI · $10.8M · Duke University
2005–2030
cGMP Manufacture, Fill-Finish, Release, Analytical and Stability Testing and Stability Program of a Nanoparticle Based HIV Envelope Vaccine
NIH Office of the Director · N01
Contact PI · $580.1K · International Aids Vaccine Initiative
2022–2027

Combating Related Epidemics in HCV
Principal investigator · Not yet recruiting · Phase 4
Duke University
2026–2030
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)
Principal investigator · Completed · Phase 3
Susanna Naggie, MD
2023–2024
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm F (Montelukast)
Principal investigator · Completed · Phase 3
Susanna Naggie, MD
2023–2024
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm E (Fluvoxamine 100)
Principal investigator · Completed · Phase 3
Susanna Naggie, MD
2022–2023